Grifols | GRFS - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
Alaunos Therapeutics USD 1.29M 865K 2026-03
Arca Biopharma USD 486.72M 17.72M 2026-03
aTyr Pharma USD 57.93M 82.05M 2026-03
Bio Path USD -8.49M 482K 2026-03
Brainstorm Cell Therapeutics USD -11.01M 1.02M 2026-03
Capricor Therapeutics USD 278.7M 27.09M 2026-03
Cara Therapeutics USD 14.5M 6.44M 2026-03
GlaxoSmithKline GBP 17.64B 223M 2026-06
Grifols EUR 6.21B 133.12M 2025-12
Immunic USD 151.23M 157.91M 2026-03
Minerva Neurosciences USD -140.75M 106.17M 2025-12
Nektar Therapeutics USD 576.22M 486.38M 2026-03
Sangamo BioSciences USD 19.6M 14.7M 2025-06
TherapeuticsMD USD 27.67M 990K 2024-06